Blood transfusion activity in a general hospital during the COVID-19 pandemic.
COVID-19
patient blood management
transfusion
Journal
Vox sanguinis
ISSN: 1423-0410
Titre abrégé: Vox Sang
Pays: England
ID NLM: 0413606
Informations de publication
Date de publication:
May 2021
May 2021
Historique:
revised:
24
09
2020
received:
27
05
2020
accepted:
13
10
2020
pubmed:
3
11
2020
medline:
3
7
2021
entrez:
2
11
2020
Statut:
ppublish
Résumé
The COVID-19 outbreak has affected almost all hospital departments, including transfusion services. However, the demand for transfusions in a general hospital designated to deal with COVID-19 patients has not been analysed before. A retrospective study was conducted to evaluate blood transfusion practices from 15 March to 14 April 2020 at Hospital Universitario Infanta Leonor (Madrid, Spain). During this month, with few exceptions, the hospital became a 'COVID-19' centre. In addition, transfusion rates during this time frame and the same period over the last 4 years were compared. From 15 March to 14 April 2020, only 254 blood components were transfused, resulting in a 49·3% reduction over the previous year. Interestingly, in critically ill patients, the red blood cell (RBC) transfusion/bed ratio significantly decreased during this period (0·92) compared to the same ratio over the past 4 years (2·70) (P = 0·02). Of note, 106 blood components (95 RBC; 11 platelet concentrates) were transfused to only 36 out of 1348 COVID-19 patients (2·7%). The main reason for RBC transfusion in COVID-19 patients was a previous underlying disease (44%) followed by bleeding (25%) and inflammatory anaemia (25%). This is the first study to report a decrease in blood transfusions during the COVID-19 pandemic in a general hospital and especially in the intensive care unit. The results of this study suggest that COVID-19 does not generally induce transfusion requiring anaemia, being the main causes for transfusion in these patients underlying conditions or bleeding.
Sections du résumé
BACKGROUND
BACKGROUND
The COVID-19 outbreak has affected almost all hospital departments, including transfusion services. However, the demand for transfusions in a general hospital designated to deal with COVID-19 patients has not been analysed before.
STUDY DESIGN AND METHODS
METHODS
A retrospective study was conducted to evaluate blood transfusion practices from 15 March to 14 April 2020 at Hospital Universitario Infanta Leonor (Madrid, Spain). During this month, with few exceptions, the hospital became a 'COVID-19' centre. In addition, transfusion rates during this time frame and the same period over the last 4 years were compared.
RESULTS
RESULTS
From 15 March to 14 April 2020, only 254 blood components were transfused, resulting in a 49·3% reduction over the previous year. Interestingly, in critically ill patients, the red blood cell (RBC) transfusion/bed ratio significantly decreased during this period (0·92) compared to the same ratio over the past 4 years (2·70) (P = 0·02). Of note, 106 blood components (95 RBC; 11 platelet concentrates) were transfused to only 36 out of 1348 COVID-19 patients (2·7%). The main reason for RBC transfusion in COVID-19 patients was a previous underlying disease (44%) followed by bleeding (25%) and inflammatory anaemia (25%).
CONCLUSION
CONCLUSIONS
This is the first study to report a decrease in blood transfusions during the COVID-19 pandemic in a general hospital and especially in the intensive care unit. The results of this study suggest that COVID-19 does not generally induce transfusion requiring anaemia, being the main causes for transfusion in these patients underlying conditions or bleeding.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
574-580Informations de copyright
© 2020 International Society of Blood Transfusion.
Références
Lai C-C, Shih T-P, Ko W-C, et al.: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges. Int J Antimicrob Agents 2020; 55:105924
WHO: Coronavirus Disease (COVID-19) Dashboard [Internet]. Available from: https://covid19.who.int [Last accessed on 2020 August 13]
Ministerio de Sanidad, Consumo y Bienestar Social: Professionals - Situación actual Coronavirus [Internet]. Available from: https://www.mscbs.gob.es/en/profesionales/saludPublica/ccayes/alertasActual/nCov-China/situacionActual.htm [Last accessed on 2020 August 13]
Liao D, Zhou F, Luo L, et al. Haematological characteristics and risk factors in the classification and prognosis evaluation of COVID-19: a retrospective cohort study. Lancet Haematol 2020; 7:e671-e678
Fan BE, Chong VCL, Chan SSW, et al.: Hematologic parameters in patients with COVID-19 infection. Am J Hematol 2020; 95:E131-E134
Zhou M, Zhang X, Qu J: Coronavirus disease 2019 (COVID-19): a clinical update. Front Med 2020; 14:126-135
Jin S, Jin Y, Xu B, et al.: Prevalence and impact of coagulation dysfunction in COVID-19 in China: a meta-analysis. Thromb Haemost 2020. https://doi.org/10.1055/s-0040-1714369
Görlinger K, Dirkmann D, Gandhhi A, et al.: COVID-19 associated coagulopathy and inflammatory response: what do we know already and what are the knowledge gaps? Anesth Analg 2020; 131:1324-1333
Raturi M, Kusum A: The blood supply management amid the COVID-19 outbreak. Transfus Clin Biol 2020; 27:147-151
Pagano MB, Hess JR, Tsang HC, et al.: Prepare to adapt: blood supply and transfusion support during the first 2 weeks of the 2019 novel coronavirus (COVID-19) pandemic affecting Washington State. Transfusion 2020; 60:908-911
Garraud O: COVID-19: is a paradigm change to be expected in health care and transfusion medicine? Transfus Clin Biol 2020; 27:59-60
Chang L, Yan Y, Wang L: Coronavirus disease 2019: Coronaviruses and blood safety. Transfus Med Rev 2020; 34:75-80
Barriteau CM, Bochey P, Lindholm PF, et al.: Blood transfusion utilization in hospitalized COVID-19 patients. Transfusion. 2020. https://doi.org/10.1111/trf.15947
Murphy C, Jackson B, Fontaine M: Tools for rapid analysis of blood usage and inventory during the COVID-19 pandemic. Transfusion 2020. https://doi.org/10.1111/trf.15996
Fan BE, Ong KH, Chan SSW, et al.: Blood and blood product use during COVID-19 infection. Am J Hematol 2020; 95:E158-E160
Cai X, Ren M, Chen F, et al.: Blood transfusion during the COVID-19 outbreak. Blood Transfus. 2020; 18:79-82
Goh KJ, Wong J, Tien J-CC, et al.: Preparing your intensive care unit for the COVID-19 pandemic: practical considerations and strategies. Crit Care Lond Engl 2020; 24:215
Stanworth SJ, New HV, Apelseth TO, et al.: Effects of the COVID-19 pandemic on supply and use of blood for transfusion. Lancet Haematol 2020; 7:e756-e764
Shander A, Goobie SM, Warner MA, et al.: Essential role of patient blood management in a pandemic: a call for action. Anesth Analg 2020; 131:74-85
Wang Y, Han W, Pan L, et al.: Impact of COVID-19 on blood centres in Zhejiang province China. Vox Sang 2020; 115:502-506
Baron DM, Franchini M, Goobie SM, et al.: Patient blood management during the COVID-19 pandemic: a narrative review. Anaesthesia 2020; 75:1105-1113
Corwin HL, Parsonnet KC, Gettinger A: RBC transfusion in the ICU. Is there a reason? Chest 1995; 108:767-771
Vincent JL, Baron J-F, Reinhart K, et al.: Anemia and blood transfusion in critically ill patients. JAMA 2002; 288:1499-1507
Jandu AS, Vidgeon S, Ahmed N: Anaemia and transfusion triggers in critically ill patients - What we have learnt thus far. J Intensive Care Soc 2019; 20:284-289
Koeckerling D, Pan D, Mudalige NL, et al.: Blood transfusion strategies and ECMO during the COVID-19 pandemic. Lancet Respir Med 2020; 8:e40
Kowalewski M, Fina D, Słomka A, et al.: COVID-19 and ECMO: the interplay between coagulation and inflammation-a narrative review. Crit Care Lond Engl 2020; 24: 205
Kamper-Jørgensen M, Ahlgren M, Rostgaard K, et al.: Survival after blood transfusion. Transfusion 2008; 48:2577-2584